Medicare formulary coverage for top-selling biologics
- PMID: 20010576
- PMCID: PMC2845541
- DOI: 10.1038/nbt1209-1082
Medicare formulary coverage for top-selling biologics
References
-
- Mullins CD, Lavallee DC, Pradel FG, DeVries AR, Caputo N. Health plans’ strategies for managing outpatient specialty pharmaceuticals. Health Aff (Millwood) 2006 Sep-Oct;25(5):1332–1339. - PubMed
-
- Robinson JC. Insurers’ strategies for managing the use and cost of biopharmaceuticals. Health Aff (Millwood) 2006 Sep-Oct;25(5):1205–1217. - PubMed
-
- Tseng CW, Mangione CM, Brook RH, Keeler E, Dudley RA. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies. JAMA. 2007 Jun 20;297(23):2596–2602. - PubMed
-
- Bowman J, Rousseau A, Silk D, Harrison C. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006. Health Aff (Millwood) 2006 Sep-Oct;25(5):1240–1248. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
